Chemical activators of CD9 are specific types of small molecules designed to modulate the activity of the CD9 molecule, which is embedded within the cell membrane and plays a role in cellular communication and structural integrity. These activators work by binding to CD9 and inducing a conformational change or by enhancing its interaction with other membrane components, such as lipids or signaling molecules. The goal is to amplify the natural functions of CD9, which may include facilitating cellular adhesion and migration, without relying on protein or peptide interactions. The chemical structure of these activators is critical as it needs to be compatible with the lipid-rich environment of the cell membrane and able to withstand the diverse range of pH levels and enzymatic activities present in the cellular milieu.
The development of small molecule CD9 activators requires a detailed understanding of the topology and biophysical properties of CD9 within the membrane. These small molecules are often designed based on the structural domains of CD9 that are accessible at the cell surface and can be targeted to influence the protein's activity from the exterior of the cell. The chemical activators usually have specific functional groups that enable them to interact with the hydrophobic and hydrophilic regions of CD9, stabilizing the protein in a particular conformation that is associated with an active state. The design process often involves iterative cycles of synthesis and testing, with modifications made to improve selectivity, potency, and the ability to integrate into the cellular environment without being rapidly degraded or ejected.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PP 1 | 172889-26-8 | sc-203212 sc-203212A | 1 mg 5 mg | $86.00 $145.00 | 6 | |
Activates Src kinase, leading to increased CD9 phosphorylation and modulating downstream signaling pathways, ultimately enhancing CD9 functional activity. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
Activates PKC, facilitating CD9 phosphorylation and reinforcing its association with integrins, thereby augmenting cell adhesion. | ||||||
W-7 | 61714-27-0 | sc-201501 sc-201501A sc-201501B | 50 mg 100 mg 1 g | $166.00 $306.00 $1675.00 | 18 | |
Antagonizes calmodulin, disrupting its interaction with CD9 and affecting downstream signaling, leading to enhanced CD9 functional activity. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
Inhibits ROCK, impacting actin cytoskeleton organization and influencing CD9-mediated processes like cell adhesion and migration. | ||||||
Bisindolylmaleimide I (GF 109203X) | 133052-90-1 | sc-24003A sc-24003 | 1 mg 5 mg | $105.00 $242.00 | 36 | |
Inhibits PKC, impacting CD9 phosphorylation and its association with integrins, thereby affecting cell adhesion and signaling. | ||||||
GW 5074 | 220904-83-6 | sc-200639 sc-200639A | 5 mg 25 mg | $106.00 $417.00 | 10 | |
Inhibits c-Raf in the MAPK pathway, indirectly influencing CD9 function by modulating downstream signaling cascades. | ||||||
Chelerythrine chloride | 3895-92-9 | sc-3547 sc-3547A | 5 mg 25 mg | $90.00 $317.00 | 17 | |
Inhibits PKC, affecting CD9 phosphorylation and its role in cellular processes like adhesion and migration. | ||||||
ML 141 | 71203-35-5 | sc-362768 sc-362768A | 5 mg 25 mg | $137.00 $512.00 | 7 | |
Inhibits Cdc42, modulating cytoskeletal dynamics and indirectly impacting CD9-mediated cellular functions, such as adhesion and migration. | ||||||